Publicly available pharmaceutical product sources identify General Pharmaceuticals Ltd. as the manufacturer of Barigen 4 mg.
Barigen product information
Reported product details include:
- Brand: Barigen
- Active ingredient: Baricitinib
- Strength: 4 mg
- Dosage form: Tablet
- Reported manufacturer: General Pharmaceuticals Ltd.
Important verification note
Barigen.com should not publish unsupported claims about:
- Manufacturing facilities
- GMP certificates
- FDA approval
- EMA approval
- WHO prequalification
- Export licenses
- Regulatory registrations
- Manufacturing capacity
- Awards
- Corporate history
unless those details are verified through authoritative sources.
Brand versus regulatory authorization
The existence of a Barigen product does not automatically mean that it has the same regulatory authorization as Olumiant in every country.
Regulatory status is product- and jurisdiction-specific.
For example, the U.S. prescribing information retrieved for this project is for Olumiant, not Barigen.
This distinction should be maintained throughout Barigen.com.